Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial (Q44899488)

7 December 2017

Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial (English)

1 reference

Adaptive radiation therapy

7 December 2017

0 references

phase III clinical trial

0 references

author

Sara Ramella

10

1 reference

7 December 2017

14

1 reference

7 December 2017

Rolando M D'Angelillo

12

0 references

Alfredo Cesario

object named as

Alfredo Cesario

9

0 references

Vincenzo Valentini

4

object named as

Vincenzo Valentini

1 reference

7 December 2017

8

Stefano Margaritora

1 reference

7 December 2017

1

Lucio Trodella

1 reference

7 December 2017

2

Pierluigi Granone

1 reference

7 December 2017

5

Mario Balducci

1 reference

7 December 2017

6

Giovanna Mantini

1 reference

7 December 2017

7

Adriana Turriziani

1 reference

7 December 2017

15

Numa Cellini

1 reference

7 December 2017

Salvatore Valente

3

1 reference

PubMed ID

11830308

7 December 2017

Giuseppe M Corbo

11

1 reference

PubMed ID

11830308

7 December 2017

Antonella Fontana

13

1 reference

7 December 2017

1 January 2002

1 reference

Radiotherapy and Oncology

7 December 2017

1 reference

7 December 2017

62

1 reference

7 December 2017

1

1 reference

7 December 2017

11-19

1 reference

Standardization of spirometry--1987 update. Statement of the American Thoracic Society

7 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

THE EFFECTS OF RADIATION THERAPY ON PULMONARY FUNCTION IN CARCINOMA OF THE LUNG

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC)--analysis of a Radiation Therapy Oncology Group (RTOG) protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Local and/or distant recurrences in T1-2/N0-1 non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Involved-field radiotherapy alone for early-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): randomised clinical study 1988-1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Postoperative radiation therapy in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Radiotherapy versus follow-up in the treatment of pathological stage Ia and Ib non-small cell lung cancer. Early stopped analysis of a randomized controlled study✩

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Toward the primary prevention of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Local recurrence of resectable non-oat cell carcinoma of the lung. A warning against conservative treatment for N0 and N1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Completion pneumonectomy: indications and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Disease recurrence after resection for stage I lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Postresection irradiation for T2 N0 M0 non-small cell carcinoma: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. The Ludwig Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Surgical treatment of non-small cell lung cancer by stage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Incidence of local recurrence and second primary tumors in resected stage I lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Expanded possibilities for surgical treatment of lung cancer. Survival in stage IIIa disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Revisions in the International System for Staging Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

What now for postoperative radiotherapy for lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

An analysis of 40 cases treated by total thoracic irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Postoperative radiotherapy after pneumonectomy: impact of modern treatment facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Postoperative radiation therapy in lung caner: a controlled trial after resection of curative design

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2801%2900478-9

7 January 2021

10.1016/S0167-8140(01)00478-9

Identifiers

DOI

1 reference

7 December 2017

1 reference

PubMed ID

11830308